Omar Ali Mather MD
Associate Vice President, Head of Therapeutic Area Safety at Amgen
Join to View Full Profile
123 Nunya Business LaneThousand Oaks, CA 91360
Dr. Mather is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Omar Mather, MD, is a pediatrician based in Thousand Oaks, CA, who completed his residency in Pediatrics at Children's Hospital Los Angeles from 2006 to 2009, following his graduation from The University of Toledo College of Medicine in 2006. His research contributions include several publications, notably in the New England Journal of Medicine, focusing on the biotechnology. His work has been cited many times, reflecting engagement with the scientific community.
Education & Training
Children's Hospital Los AngelesResidency, Pediatrics, 2006 - 2009
The University of Toledo College of MedicineClass of 2006
Certifications & Licensure
CA State Medical License 2008 - 2026
American Board of Pediatrics Pediatrics
Publications & Presentations
PubMed
- 2 citationsA Phase 1, Open-Label Study to Evaluate the Effect of Food and Concomitant Itraconazole Administration on the Pharmacokinetics of AMG 986 in Healthy Subjects.Ashit Trivedi, Omar Mather, Silvia Vega, Shauna Hutton, Jennifer Hellawell
Clinical Pharmacology in Drug Development. 2022-07-01 - 5 citationsA Phase I, Open-label, Single-Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of AMG 986 in Healthy Japanese Subjects.Ashit Trivedi, Omar Mather, Silvia Vega, Shauna Hutton, Jennifer Hellawell
Drugs in R&D. 2022-06-01 - 4 citationsEvaluation of the Pharmacokinetics and Safety of AMG 986 Tablet and Capsule Formulations in Healthy Adult Subjects: A Phase I, Open-Label, Randomized Study.Ashit Trivedi, Y-H Kiang, Robert E Saw, Guilong Charles Cheng, Omar Mather
Drugs in R&D. 2022-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
